Korea Investment Corp Amgen Inc Transaction History

Korea Investment Corp

$38.9 Billion
Q2 2024

A detailed history of Korea Investment Corp transactions in Amgen Inc stock. As of the latest transaction made, Korea Investment Corp holds 388,693 shares of AMGN stock, worth $125 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

388,693

Previous 372,047 4.47%

Holding current value

$125 Million

Previous $106 Million 14.81%

% of portfolio

0.31%

Previous 0.27%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $4.37 Million - $5.32 Million	16,646 Added 4.47%	388,693 $121 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $9.26 Million - $11.2 Million	-34,453 Reduced 8.48%	372,047 $106 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.43 Million - $1.61 Million	5,592 Added 1.39%	406,500 $117 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $8.46 Million - $10.5 Million	-38,704 Reduced 8.8%	400,908 $108 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $14.7 Million - $17.4 Million	-68,517 Reduced 13.48%	439,612 $97.6 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $501,705 - $611,494	2,222 Added 0.44%	508,129 $123 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $12.2 Million - $15.6 Million	-53,464 Reduced 9.56%	505,907 $133 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $2.59 Million - $2.92 Million	-11,533 Reduced 2.02%	559,371 $126 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $11.9 Million - $13.2 Million	51,477 Added 9.91%	570,904 $139 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $14.1 Million - $15.6 Million	64,119 Added 14.08%	519,427 $126 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $19.7 Million - $22.6 Million	99,114 Added 27.83%	455,308 $102 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $3.67 Million - $4.3 Million	-17,274 Reduced 4.63%	356,194 $75.7 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $9.83 Million - $10.9 Million	-42,064 Reduced 10.12%	373,468 $91 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $9.29 Million - $10.8 Million	-41,847 Reduced 9.15%	415,532 $103 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $19.5 Million - $23.2 Million	-90,179 Reduced 16.47%	457,379 $105 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $2.21 Million - $2.45 Million	9,400 Added 1.75%	547,558 $139 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $1.07 Million - $1.31 Million	-5,400 Reduced 0.99%	538,158 $127 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $7.85 Million - $10.4 Million	-43,100 Reduced 7.35%	543,558 $110 Million
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $8.68 Million - $11.2 Million	45,900 Added 8.49%	586,658 $141 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $4.04 Million - $4.84 Million	23,200 Added 4.48%	540,758 $105 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $566,780 - $664,394	-3,400 Reduced 0.65%	517,558 $95.4 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $14.9 Million - $16.8 Million	82,412 Added 18.79%	520,958 $99 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $4.34 Million - $5.06 Million	-24,300 Reduced 5.25%	438,546 $85.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $17 Million - $19.1 Million	-91,521 Reduced 16.51%	462,846 $95.9 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $10.8 Million - $12.2 Million	-65,200 Reduced 10.52%	554,367 $0
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $11.1 Million - $13 Million	-65,592 Reduced 9.57%	619,567 $106 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $5.89 Million - $6.59 Million	34,922 Added 5.37%	685,159 $119 Million
Q3 2017 Oct 25, 2017	BUY	$167.29 - $191.0 $109 Million - $124 Million	650,237	650,237 $121 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Amgen Inc Transaction History